Pharmabiz19m
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale: Shardul Nautiyal, Mumbai Friday, November 29, 2024, 08:00 Hrs [IST] The pharmaceutic ...
Pharmabiz19m
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departm ...
Pharmabiz19m
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departmen ...
Pharmabiz19m
UPF assures of 18 guarantees in its manifesto for election to WB SPC
UPF assures of 18 guarantees in its manifesto for election to WB SPC: Peethaambaran Kunnathoor, Chennai Friday, November 29, 2024, 08:00 Hrs [IST] Ahead of the upcoming state phar ...
Pharmabiz19m
Evidence-based clinical studies a cornerstone for advances in surgical technologies: Rohit Mahajan
Evidence-based clinical studies a cornerstone for advances in surgical technologies: Rohit Mahajan: Nandita Vijayasimha, Bengaluru Friday, November 29, 2024, 08:00 Hrs [IST] Evide ...
Pharmabiz16h
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India: ...
Pharmabiz15h
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world: Our Bureau, Mumbai Thursday, November ...
Pharmabiz11h
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours
Exelixis, a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care, announced that the US FDA has notified the company that the ...
Pharmabiz14h
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA: Calgary, Alberta Thursday, November 28, 2024, 18:00 Hrs [IST] Calg ...
Pharmabiz17h
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
Pharmabiz17h
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...
Pharmabiz17h
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth: Our Bureau, Bengaluru Thursday, November 28, 2024, 15:15 Hrs [IST] Organisation of Pharmaceutical ...